Toxicology Flashcards

1
Q

Calcium Channel Blockers

2016

Slow release verapamil overdose
Interpret ECG and give management plan

Tips:
- CCB toxicity causes hyperglycaemia, BB toxicity does not

  • BB cause reduced LOC. GCS is maintained in CCB tox
  • high dose insulin takes 30-45min to work so it needs to be started ASAP

Need early arterial line

Need early central line for 50% dextrose, calcium chloride and vasopressors

Bedside echo to see if problem is vasodilation or pump failure

Adrenaline for non-dihydropyridines (verapamil, diltiazem)
Noradrenaline for dihydropyridines (amlodipine, nifedipine)

Adrenaline infusion
Draw up 6 mL of adrenaline 1:1000 solution. This contains 6 mg of adrenaline. Add to 94 mL of 5% dextrose.
The resulting solution contains adrenaline 60 micrograms/mL, so that an infusion of 1 mL/hour delivers 1 microgram/minute

A

Reference: Toxicology handbook

FEATURES:

bradycardia, heart block, hypotension, refractory shock

  • hyperglycemia and metabolic acidosis

seizure and coma are rare (coma suggests co-ingestant)

MANAGEMENT:

ATROPINE 1.2mg IV (probably won’t work)

CALCIUM:

calcium gluconate 10% 30 mL IV over 2-3min, followed by calcium gluconate 10% infusion 30ml/hr

calcium chloride 10% 10 mL IV over 2-3min, followed by calcium chloride 10% infusion 10ml/hr through a central line

HIGH DOSE INSULIN EUGLYCEMIC THERAPY:

  • 1u/kg slow IV push, followed by infusion 1u/kg/hr
    uptitrate insulin every 15min (max dose 10u/kg/hr)
  • 50ml 50% dextrose IV push followed by infusion 20ml/hr

Glucagon 1mg IV

DECONTAMINATION:
Activated charcoal 1g/kg with 1hr or 4hrs for XR preparations

WHOLE BOWEL IRRIGATION
NGT and confirm position with CXR
- Polyethylene glycol 2L/hr (25ml/kg/hr in child) until watery diarrhoea runs clear

High flow oxygen
GCS and airway reflexes are usually maintained (reduced LOC indicates beta blocker overdose or co-ingestion)

Invasive BP monitoring with arterial line activated

Fluid resuscitation 20ml/kg IV

Adrenaline (not usually effective) 10-20mcg IV followed by infusion 1mcg/kg/min

Potassium replacement (hypokalemia with insulin) 10mmol/hr

Consider:

Transcutaneous pacing (often can’t get capture)

20% intralipid 1.5ml/kg IV bolus

ECMO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acute digoxin toxicity

2021.2 CBD station

Discuss with the examiner, the assessment and management of a patient with acute digoxin toxicity.

Medical Expertise: Assessment and Diagnosis (30%)
* Correctly interprets the ECG
* Formulates a provisional diagnosis to match the immediate issues
* Identifies the elements that must be sought on initial assessment to formulate an initial management plan

Medical Expertise: Management – (40%)
* Outlines an overall plan for resuscitating a patient
* Initiates treatments specific to identified severe abnormalities in circulation
* Creates a safe and clear disposition plan for a patient

Prioritisation and Decision Making (30%)
* Highlights high-risk features identified during patient assessment
* Summarises and prioritises the key issues that must be addressed during and following the
emergency encounter
* Involves toxicology for additional expertise

Candidates were required to interact with the examiner and to:
* interpret the ECG
* provide their risk assessment for this patient
* answer further questions from the examiner as the case unfolds.

DIFFERENTIAL DIAGNOSIS for bradycardia & hypotension:

Toxicological causes:
- calcium blocker toxicity
- beta blocker toxicity
- digoxin toxicity

Non-toxicological causes:
- hypothyroid myxoedema
- severe hypothermia
- severe hyperkalemia
- inferior MI with AV block or cardiogenic shock
- raised intracranial pressure (imminent brain herniation)
- spinal cord injury

A

Digoxin has a narrow therapeutic index

Chronic digoxin toxicity has higher mortality. Classic triggers include volume depletion/renal failure (digoxin is renally excreted) and medication changes/interactions.
- pre-existing hypokalemia and hypomagnesia can also trigger toxicity

CLINICAL FEATURES:

CVS - bradycardias with AV block, hypotension, syncope, arrythmias, cardiac arrest

GI - nausea and vomiting

CNS - delirium, confusion, lethargy

Eyes - chromatopsia - abnormal colour vision, xanthopsia - yellow colour vision, reduced VA

ECG:

Digitalis effect:
- salvador dali scooped ST segments

Digoxin toxicity:
- premature ventricular contractions/PVC’s (most common)
- slow AF
- AV block
- Junctional escape rhythm
- bidirectional tachycardia
- hyperkalemia ECG

ASSESSMENT:
HISTORY:
How much?
When?
Co-ingestion?
Intentional?
Self decontamination - vomiting
Body weight?
Co-morbidities?
Symptoms? GI upset, weakness, confusion

EXAMINATION:
Level of alertness
GCS
BP, HR,
Signs of dehydration - dry mm’s, poor skin tugor
POCUS assessment of IVC, cardiac, lungs

INVESTIGATIONS:

ECG and cardiac monitoring - dysrhythmias

Digoxin level:
- digoxin levels do not correlate with toxicity
- digoxin levels cannot be interpreted if given digoxin immune fab

Acute ingestion - baseline digoxin level, then 6hrs post ingestion (takes 6hrs to distribute to tissues)

Chronic ingestion - single level 6hrs post last dose

UEC - hyperkalemia (important marker of mortality - high mortality with K+ >5.5

UEC - renal failure as cause for toxicity

VBG - acidosis, K+ (high or low), lactate (hypoperfusion), BSL if altered mentation

MANAGEMENT:
Resuscitation
Call for help, extra staff
Cardiac monitoring - dysrhythmias
Pulse oximetry
Oxygen - 2L NP, target Sa)2 100%
2x large bore IV canulae

DECONTAMINATION with activated charcoal if alert, protecting own airway and within 2hrs of acute ingestion

ANTIDOTE:
digoxin specific antibody fragments ‘digibind’

DOSE:
cardiac arrest:
- 5 vials = 200mg
not in cardiac arrest:
- 2 vials = 80mg (can repeat dose in 30min)

INDICATIONS FOR DIGIBIND:
- haemodynamic instability
- hyperkalemia >5
- Acute ingestion >10mg in adults, >4mg in children
- 6h digoxin level >10nanomol/L
- End organ dysfunction (Renal failure, Altered mentation)

DIGIBIND COMPLICATIONS:
- Hypokalemia
- Exacerbation of heart failure
- Serum sickness
- Anaphylaxis

Seek urgent toxicologist advice if serum digoxin >20nanomol/L

FLUID RESUSCITATION:
- may exacerbated CHF
- resuscitation should be guided by frequent POCUS IVC, heart and lung assessment

BRADYCARDIA:
- treated with digibind
- may temporise with atropine

Not for TRANSCUTANEOUS PACING or TRANSVENOUS PACING as the myocardium is irritable and can precipitate ventricular arrythmias

HYPERKALEMIA:
- Digibind is the preferred treatment
- Calcium is NOT contraindicated
- Can temporise with insulin, sodium bicarbonate, salbutamol until digibind is given

HYPOKALEMIA:
- Hypokalemia will exacerbate digoxin toxicity, so it must be treated
- digibind will drop K+ further so this needs to be corrected before giving digibind

HYPOMAGNESIA:
- low Mg+ will exacerbate dig tox
- treat with IV magnesium 2g over 20min

DISPOSITION:
Admit for 72hr cardiac monitoring if digi fab given

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Tricyclic Antidepressants

A

PHYSIOLOGY:
- Sodium channel blockade - prolong QRS
- Anticholinergic
- Alpha 1 blockade - vasodilation
- Antihistamine - somnolence

ANTICHOLINERGIC EFFECTS
- mydriasis
- dry, flushed skin
- urinary retention
- fever
- delirium

OTHER Na+ CHANNEL blockers:
- propanolol
- fleicanide
- carbamazipine
- quinidine
- quinine

TOXIC DOSE:
<5mg/kg = usually non-toxic
5-20mg/kg = sedation and anticholinergic effects
>20mg/kg = severe toxicity

ECG:
Sinus tachycardia due to anticholinergic effects (Muscarinic)
Wide QRS
>100ms seizures likely
>160ms ventricular arrythmias likely
Terminal R wave >3mm in aVR
or R/S ratio >0.7 in aVR

Acidosis enhances drug binding to Na+ channels. This increases Na+ blockade effects.

MANAGEMENT:

Treat seizures aggressively with benzodiazepine to prevent acidosis

Treat arrythmias, QRS widening, acidosis with sodium bicarbonate 8.4% 2ml/kg up to 100ml IV bolus, repeat every 3-5min to maintain pH 7.45-7.55
Monitor serum Na+ <155

TREAT HYPOTENSION:
- fluid resuscitation 500ml hartmann’s IV bolus (target MAP 65)
- noreadrenaline infusion 0.2-1mcg/kg/min (target MAP 65)

TREATMENT GOALS:
QRS <100ms
pH 7.5-7.55
avoid excessive hypernatremia
Monitor K+ & Ca+ (bicarbonate causes drop)

SECOND LINE:
Lignocaine for refractory ventricular arrythmias
- 1.5mg/kg (100mg) IV over 2-3min

THIRD LINE:
Intralipid 20%
1.5ml/kg (100ml) over 2-3 min
repeat bolus 0.75ml/kg (50ml) over 2-3min
start infusion 1.5ml/kg/hr

INTUBATION:

Early intubation indicated in severe toxicity

Avoid acidosis at induction

Give sodium bicarb before induction allow patient to blow off CO2 from the infused bicarbonate

Noradrenaline infusion 0.2-1mcg/kg/min (target MAP >65)

Fluid resuscitation 500ml crystalloid IV

Induction agent - ketamine 1-2mg/kg
Paralytic - suxamethonium 1-2mg/kg

Most experience operator

Bag mask ventilation during apnoeic period

POST INTUBATION:
- Hyperventilate post intubation
aim for PCO2 20
- post intubation sedation with propofol infusion 4-12mg/kg/hr (antiepileptic properties)
-

GIT decontamination

  • Activated charcoal down NGT if intubated 1g/kg up to 50g
  • Anticholinergic effects slow gastric motility so still effective 4hrs post ingestion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Paediatric Poisoning

2023.2 CBD station

Essential oil poisoning in paediatric

Outline assessment and management

Tips:
- suspet NAI/intentional poisoning in age <6 months or >5yrs
- meticulous documentation and mandatory reporting
- in unclear situations, admit the child for observation to allow time for social work to evaluate circumstances fully

Red flags for NAI:
- presentation inconsistent with history
- caregive recount of events changes
- non-ambulant child <6months
- carefully review how the child gained access to poison
- long time between ingestion and presentation
- signs of physical abuse (bruises, burns, dirty and unkempt)
- documented history of abuse
- maunchausen syndrome by proxy
- poison is alcohol or recreational drugs

Concerning paediatric toxins:
- fleicanide
- TCA’s
- beta blockers (propanolol, sotalol)
- non-dihydropyridine calcium channel blockers (verapamil, diltiazem)
- opioids (hydromorphone, methadone)
- sulphonyurea (glipizide)
- salicylates (oil of wintergreen)

A

Essential oils poisoning

Clove & Pennyoral - need urgent discussion with toxicologist as they cause same sequela as paracetamol poisoining - hepatotoxicity, renal failure, DIC and coma

Oil of wintergreen - salicylates poisoing

Eucalyptus oil

Children can have toxicity to the essential oil itself, or the HYDROCARBON used to prepare it

Hydrocarbons:
- rapid CNS depression, coma and seizures within 2hrs
- aspiration –> chemical pneumonitis
(cough, gagging, wheeze = aspiration)
(haemoptysis, hypoxia, pulmonary oedema - late sign)

ASSESSMET:
History:
- what oil ingested, concentration
- when
- co-ingestion
- self decontamination
- syptoms of toxicity and progression
- any indication of NAI, intentional overdose, neglect
- child weight
- medical co-morbidities
- regular medications

BSL
ECG
VBG - respiratory failure in aspiration
Paracetamol level
FBC, UEC, LFT’s - pennyroyal and clove oil can cause significant hepatotoxicity
CXR - pneumonitis

MANAGEMENT:

High flow 100% oxygen 15L NRBM
Bronchodilators for wheeze in aspiration pneumonitis
- nebulised salbutamol 2.5-5mg

Discuss with toxicologist for consideration of NAC in pennyoral or clove poisoning

Decontmination:
- essential oils are well absorbed through mucous membranes and the skin
- wash skin with soapy water
- irrigate eyes

  • Activated charcoal don’t bind to hydrocarbons
  • Aspiration is managed with oxygen and bronchodilators
  • Antibiotics aren’t indicated in chemical pneumonitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Polypharmacy Overdose

2023.2 RMO interaction

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Paediatric Iron Overdose

  • the amount of elemental iron ingested determines the risk, not the amount of iron salt

ASSESSMENT:

  • dose of elemental iron (mg/kg)
  • preparation (immediate release vs extended release)
  • when
  • co-ingestion
  • self decontamination (vomiting)
  • syptoms of toxicity and progression
  • any indication of NAI, intentional overdose, neglect
  • child weight
  • medical co-morbidities
  • regular medications

Tips:
- charcoal does not bind iron
- discuss with toxicologist in severe toxicity

A

DOSE RESPONSE:
<20mg/kg - asymptomatic
20-60mg/kg - GI upset
60-120mg/kg - metabolic acidosis, altered mental state
>120mg/kg - coma, seizure, arrythmias, end organ failure

CLINICAL FEATURES:
Gstrointestinal phase 0-6hrs:
- corrosive effect on GI tract
- haemorrhagic gastroenteritis
- massive fluid losses

Latent phase 6-24hrs:
- resolution of GI symptoms
- ongoing iron absorption
- evolving metabolic acidosis

Cardiogenic shock & multiorgan failure 24-48hrs:
- refractory hypotension
- pulmonary oedema
- coma & seizures
- liver failure + loss of synthetic function
- DIC

3-4days
Hepatic necrosis phase

2-8 weeks:
GI scarring and strictures leading bowel obstructions

c)
BSL - hypoglycemia

VBG - HAGMA

Iron level at 4-6hrs post ingestion (levels >90micromol/L will require Desferroxamine)

AXR - iron is radio-opaque, can help quantify ingestion and assess effective whole bowel irrigation

AXR is not indicated in liquid iron ingestion

UEC - renal failure, significant electrolyte imbalances with diarrhoea and vomiting
LFT’s - transaminitis, liver failure
BSL - hypoglycemia with liver failure
Coags - high INR with liver failure
G&H - encase of massive GI haemorrhage requiring blood transfusion

DECONTAMINATION:
Whole bowel irrigation
Polyethylene glycol 2 L/h in adults, children 25 mL/kg per hour (maximum 2 L/h)
- place nasogastric tube
- 25ml/kg/hr
- contraindicated in GI bleeding and bowel obstruction

Endoscopic retrieval of iron tablets

Charcoal does not bind iron

ANTIDOTE:
Discuss with toxicologist
Desferroxamine 15/kg/hr IV infusion

Desferrioxamine is a chelating agent that forms a water soluble desferrioxamine-iron complex so that it is excreted in urine
- if oligouric renal failure will need consideration of haemodialysis

For Serum iron >90micromol/L or obvious severe systemic toxicity

Desferrioxamine infusions usually for 12-16hrs OR
- The child is asymptomatic
- Decontamination complete
- Anion-gap acidosis resolved
- Serum iron concentration <60 micromol/L

List four (4) criteria that must be met for safe discharge home from ED:

  • Clinically well 6 hours after ingestion for IR or 12 hours after ingestion for XR iron preparation.
  • Peak serum iron concentration <90 micromol/L
  • No iron on AXR
  • No evidence of metabolic acidosis
  • No suspicion of intentional poisoning, NAI, neglect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Adult Polypharmacy Overdose

2023.2 RMO interaction

Assessment and management

Consider different toxidromes

ECG findings

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Toxidromes

Anticholinergic - atropine, amitriptyline, antihistamines

Features:

  • Altered mental status - mad as a hatter
  • Mydriasis
  • Dry flushed skin - red as a beet
  • Urinary retention
  • Decreased bowel sounds
  • Fever
  • Dry mucous membranes
  • Seizures, arrhythmias, rhabdomyolysis

Cholinergic - organophosphates

Features:

  • Miosis
  • Salivation
  • Lacrimation
  • Diaphoresis
  • Vomiting
  • Urination
  • Defecation
  • Bronchorrhoea
  • Muscle fasciculations
  • Weakness
  • Bradycardia, seizures

Opioid - heroin, morphine, hydromorphone, methadone

Features:

  • Miosis
  • Respiratory depression
  • CNS depression
  • Hypothermia
  • Bradycardia

Sympathomimetic - cocainne, amphetamines

Clinical features:

  • Agitation
  • Tachycardia
  • Hypertension
  • Hyperpyrexia
  • Diaphoresis
  • Fever
  • Seizures, acute coronary syndrome

Thyrotoxicosis
Heat stroke

Salicylates - aspirin, oil of wintergreen

Features:

  • Altered mental status
  • Respiratory alkalosis
  • Metabolic acidosis
  • Tinnitus
  • Tachypnea, tachycardia, diaphoresis, nausea, vomiting
  • Hyperpyrexia (low grade)

Extrapyramidal - haloperidol, risperidone

Features:

  • Dystonia
  • Torticollis
  • Muscle rigidity
  • Choreoathetoid movements
  • Hyperreflexia
  • Seizures

Hypoglycemia - insulin, sulphonyureas

Features:

  • Altered mental status
  • diaphoresis
  • tachycardia
  • hypertension
  • Dysarthria, behavioral change, seizures

Neuroleptic malignant syndrome - antipsychotics

Features

  • Lead-pipe muscle rigidity
  • Bradyreflexia
  • Hyperpyrexia
  • Altered mental status
  • Autonomic instability
  • Diaphoresis
  • Mutism
  • Incontinence

Serotonin syndrome -
fluoxetine

Features:

  • Altered mental status
  • Hyperreflexia and hypertonia (>lower limbs)
  • Clonus
  • Tachycardia
  • Diaphoresis
  • Hypertension, flushing, tremor
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Paediatric Poisoning

2023.1 CBD station

paediatric with poisoning

perform a risk assessment

patient deteriorates and requires intubation

Concerning poisons in paediatrics:
- calcium channel blockers
- sulphonyureas
- TCA
- iron
- propanolol
- fleicanide
- opioids (methadone, hydromorphone)
- essential oils, hydrocarbons, camphor, pennyroyal, clove
- paraquat
- organophosphates
- moth balls

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Organophosphate / Carbamate Toxicity

2022.1 discussion with registrar station

Medical Expertise: Assessment – 40%
* Elicits a focused, relevant history of organophosphate exposure
* Performs a focused, structured and relevant physical examination of the patient with
organophosphate poisoning
* Identifies risks of deterioration/need for intervention in the patient with organophosphate
toxicity.
Medical Expertise: Management – 40%
* Outlines an appropriate plan regarding decontamination of a patient with organophosphate
poisoning
* Outlines an overall plan for the management of the patient with established organophosphate
toxicity.
Prioritisation and Decision Making – 20%
* Lists specific triggers for intubation in a patient with organophosphate toxicity.
Candidates were required to interact with a junior registrar (role player) and to:
* answer the registrar’s questions regarding this patient’s presentation.

A

Pesticides & insecticides used in agriculture
- carbamates are less toxic than organophosphates and have shorter duration of action
- any ingestion in children can be lethal
- deliberate ingestion in adults will cause life threatening toxicity
- accidental dermal or inhalational exposure causes toxicity but is rarely life threatening

***Large amounts of atropine, hundreds of milligrams, may be necessary in massive ingestions. Proactive contact with the hospital pharmacy (or even other centres) may be necessary to ensure access to adequate amounts of atropine.

MECHANISM:
- inhibits acetylcholinesterase
- accumulation of acetylcholine at muscurinic and nicotinic receptors

HISTORY:
Which agent ingested?
When?
How much?
Co-ingestion?
Self decontamination with emesis?
Symptoms since ingestion?

“Cholinergic crisis”
Muscurinic effects ‘DUMBBELS’
- diarrhoea & diaphoresis
- urinarion
- miosis
- bronchorrhoea & bronchospasm
- bradycardia & hypotension
- emesis
- lacrimation
- salivation

Nicotinic effects:
- fasciculations
- tremor
- weakness
- respiratory muscle paralysis
- tachycardia/hypertension

CNS effects- agitation, coma, seizures

Respiratory effects:
- progressive neuromuscular junction dysfunction and respiratory failure over 1 to 4 days
- Chemical pneumonitis (if contains hydrocarbons)

Intentional - Will need psychiatric assessment

EXAMINATION:
Bradycardia or tachycardia
hypotension or hypertension
Respiratory distress - dyspnoeic, hypoxic, wheeze

GCS - coma, confused, delirius
seizures

diaphoresis
miosis
lacrimation
salivation
vomiting

incontinent - urine, diarrhoea

INVESTIGATIONS:
ECG - arrythmia
CXR - chemical pneumonitis

*plasma cholinesterase activity - if the diagnosis is unclear

*red cell cholinesterase activity - better correlation with severity of poisoning

MANAGEMENT:
PPE - impervious gown, gloves, mask, eye protection for resus team

DECONTAMINATION:
- no role for activated charcoal with oral ingestion as rapidly absorbed and distributed
- remove and dispose of clothing, wash skin with water and detergent for dermal exposures

ENHANCED ELIMINATION:
- none

ANTIDOTE:
atropine 1.2mg (0.05mg/kg) IV
double dose every 5min until adequate atropinisation - chest clear, no wheeze
- HR 80
- SBP >80
then use 10-20% of the loading dose per hour infusion

reduce infusion if over atropinisation
- confusion
- pyrexia
- mydriasis
- absent bowel sounds

*Atropine has no effects on the neuromuscular junction

PRALIDOXIME:
- controversial
- causes reactivation of acetylcholinesterase with SOME organophosphate poisonings (not carbamate poisonings)
- studies have shown that although it does increase red cell cholinesterase activations, it does not improve survival or intubation rates
- if poisoning is refractory to atropine, discuss use of pralidoxime with toxicologist

CHEMICAL PNEUMONITIS
- oxygen
- ventilatory support
- steroids

SEIZURES:
- midazolam 5mg IV

AGITATION:
- midazolam

RESPIRATORY FAILURE:
- Intubation and mechanical ventilation

EARLY INTUBATION:
*atropine improves wheeze and clears secretions but DOES NOT reverse respiratory muscle paralysis
*also many have an aspiration pneumonitis

OPTIMISE PRE-INTUBATION:
- Preoxygenate
- Fluid resuscitation
- Noreadrenaline infusion

  • using ketamine 1mg/kg and rocuronium 1.2mg/kg

***A non-depolarizing agent should be used when neuromuscular blockade is needed.
Succinylcholine is metabolized by plasma butyrylcholinesterase; therefore, prolonged paralysis may result.

  • using video laryngoscope and experienced operator to increase likelihood of first pass success.

DISPOSITION:
ICU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Toxic Alcohol Poisoning
- methanol
- ethylene glycol

2021.1 CBD station

Assessment and management of an adult female who has been brought to the ED in a highly agitated state.

Interpret VBG

Differential diagnosis for HAGMA
“MUD PILES”

Metformin, Methanol
Uremia
DKA
Paracetamol toxicity
Iron toxicity, Isoniazid
Lactic acidosis (sepsis)
Ethanol, ethylene glycol
Salicylates

Anion gap = Na+ - Cl - HCO3-
normal anion gap =12

Osmolar gap = measured osmolarity - calculated osmolarity

calculated osmolarity = (2x Na+) + glucose + urea

normal osmolar gap = <10

Outline your care for the obtunded patient

Signs of hypocalcemia “CATs go numb”
Convulsions
Arrythmias (prolonged QTc)
Tetany
numbness (perioral, hands, feet parasthesias)

Trousseau sign
Chvostek sign

A

Ethylene glycol + Methanol

Methanol - poorly distilled alcohol

Ethylene glycol - antifreeze, break fluid and some solvents

Metabolised by alcohol dehydrogenase and aldehyde dehydrogenase to form toxic metabolites

ethylene glycol –> oxalic acid –> calcium oxalate precipitation in kidneys and brain

methanol –> formic acid –> affects retina + basal ganglia

Fomepizole inhibits alcohol dehydrogenase

haemodialysis removes toxic metabolites
- formic acid
- glycolic acid
- oxalic acid

PRESENTATION:
- drunk
- hyperventilation (due to metabolic acidosis)
- reduced visual acuity with methanol - “snow storm vision”
- become more obtunded
- seizure (due to hypocalcemia)

ECG - prolonged QTc with hypocalcemia

*HAGMA
*raised osmolar gap
*lactic acidosis

*hypocalcemia
*hypoglycemia
*hyperkalemia

*calcium oxalate crystals in urine

*raised serum methanol or ethylene glycol levels
- gas chromatography is not widely available
*methanol level >15mmol/L
*ethylene glycol level >8mmol/L
are associated with severe toxicity in adults and children

measure serum ethanol levels

DECONTAMINATION:
- charcoal doesn’t bind alcohols

ANTIDOTE:
- fomepizole (inhibit alcohol dehydrogenase)
- 15mg/kg Q12hr
- very expensive and not readily available
- toxic alcohols have long half lives so prolonged treatment required

Second line:
- Ethanol 10% 6 mL/kg IV or NGT loading dose, followed by 50-100ml/hr infusion

If ethanol 10% is not available, then white spirits (eg vodka), can be administered orally or via a nasogastric tube. Use serial serum ethanol concentrations to guide the rate of administration.

ethanol 0.6 g/kg orally or via nasogastric tube, as a loading dose

ethanol 5 -10 g/hour (child: 0.1 to 0.2 g/kg/hour up to 10 g/hour) via nasogastric tube. Measure the serum ethanol concentration regularly and aim to maintain a serum ethanol concentration 22-44 mmol/L

Need to double the dose of ethanol if having dialysis. Aim for serum ethanol 22-44mmol/L

ENHANCED ELIMINATION:
- haemodialysis removes toxic metabolites
- shorten hospital length of stay

Indications for haemodialysis:
- pH <7.15
- end organ damage (renal failure, coma, seizures, blindness)
- high serum levels

continue fomepizole during dialysis

don’t treat hypocalcium unless tetany, seizures, QT prolongation - giving calcium will precipitate calcium oxylate in the tissues

Patient is obtunded and has a seizure. Outline your management.

  • Intubate and hyperventilate
  • Sodium bicarbonate 50-100ml IV bolus for acidemia

Ethanol 10% 6 mL/kg IV or NGT loading dose, followed by 50-100ml/hr infusion

Fomepizole 15 mg/kg IV loading, then 10mg/kg IV BD, dosing increases to Q4h during dialysis

Folic acid 50mg IV QID - for methanol poisoning. metabolises formic acid to non-toxic metabolite.

Thiamine 300mg IV daily OR Pyridoxime 50mg IV QID for ethylene glycol poisoning. metabolises oxalic acid to non-toxic metabolite.

Dialysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Snake Bite

2023.1 Teaching Station

Discuss with a junior doctor (role player) the approach to
the assessment and management of a patient with snakebite.

A

INVESTIGATIONS:

Coags:
“complete VICC” is defined as:
INR >3
undetectable fibrinogen
D-dimer >100x normal limit
~~~

“partial VICC” is defined as:
INR<3
low but detectable fibrinogen

FBC

  • Hb drop (bleeding)
  • Neutrophilia
  • Thrombocytopenia

Group and Hold /Cross match
- Bleeding risk

UEC

  • Hyperkalaemia in rhabdomyolysis
  • Renal impairment in rhabdomyolysis

Urine analysis

  • Haematuria
  • Myoglobinuria (rhabdomyolysis)

CK
- raised in rhabdomyolysis

VBG to assess ventilation and oxygenation in respiratory failure

Swab for SVDK

  • Cut window in pressure bandage to access bite
  • Urine sample for SVDK

Repeat bloods 1hr after removal of pressure bandage
Repeat bloods at 6hrs and 12hrs post bite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Neuroleptic Malignant Syndrome

A
  • Caused by dopamine antagonists (any antipsychotics) or stopping dopaminergic drugs Ievodopa, carbidopa, bromocryptine

Ref: Tintinalli’s Table
Diagnostic Criteria for Neuroleptic Malignant Syndrome

Major features

  • Fever >38°C
  • Lead-pipe muscle rigidity
  • Psychomotor slowing and altered mental status
  • Sympathetic nervous system lability (2 or more)
    - Hypertension
    - Diaphoresis
    - Urinary incontinence
  • Recent dopamine antagonist or cessation of dopamine agonist

Minor features

  • Raised CK (> 4 × upper limit) or Myoglobinuria
  • Tachycardia
  • Tachypnoea
  • Hypersalivation
  • Tremor
  • Muscle cramps

Exclusion criteria
- no other infectious, toxic, metabolic or neurological cause identified

Differentiation from Serotonin syndrome
*slower onset

  • No ocular myoclonus
  • limb rigidity is common in NMS but a late sign in serotonin syndrome

hyperreflexia and clonus in serotonin syndrome
decreased or absent deep tendon reflexes in NMS

*bowel sounds increased in serotonin syndrome
(normal or decreased in NMS)

  • severe rhabdomyolysis in NMS (rhabdo is rare in serotonin syndrome)
  • hyperthermia is more prominent in NMS (mild in serotonin syndrome)
  • seizures uncommon in serotonin syndrome
  • pupils dilated in serotonin syndrome (usually normal in NMS)

“SPROD RHHOB”

S - seizure (more common in SS)
P - pupils (mydriasis in SS)
R - rigidity (NMS)
O - onset (rapid in SS)
D - Delirium (in NMS)

R - rhabdomyolysis (more pronounced in NMS)
H - hyperthermia (more pronounced in NMS)
H - hyperreflexia (in SS)
O - ocular clonus (in SS)
B - bowels (diarhhoea in SS)

MANAGEMENT:

Withdraw antipsychotics

Fluid resuscitation

Treat hyperthermia
- cooling

Sedation with benzodiazepines

Airway protection - especially if hypersalivation
- Non-depolarizing neuromuscular blocking agents

Consider agents to reduce severe muscle rigidity

Dantrolene, 2.5 mg/kg IV load, followed by 1mg/kg IV QID

OR

Bromocriptine 2.5mg PO TDS

or

Amantadine, 100mg PO TDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The Agitated Patient

Excited delirium

A

MANAGEMENT:

Danger to patient and staff

Apply high flow oxygen with a non-rebreather mask - provides oxygen but also stops spit

Give IM droperidol 10mg IM through the clothes to lateral thigh, repeat 10mg IM

Alternative ketamine 400mg IM (4-6mg/kg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Methaemoglobinaemia

A 12 year old boy has had a Biers Block performed for manipulation of a distal radius/ulnar fracture.

During the procedure he develops Methaemoglobinaemia.

A

METHAEMGLOBINAEMIA:
- The ferrous (HbFe2+) form of iron is needed to bind oxygen.
- in MetHb red blood cells are oxidised to the ferric state and can no longer bind or transport oxygen.
- G6PD deficiency
- paediatrics > adults
- not dose related

TRIGGERS:
Local anesthetics:
“PBL”
- Prilocaine
- Benzocaine
- Lignocaine

Nitrates:
- GTN
- Inhaled nitric oxide.
- Nitroprusside
- Amyl nitrate.

Antibiotics:
- Dapsone.
- Rifampin.

Antimalarials (chloroquine, primaquine).

Methaemoglobin level:
<2% is normal.
3-15%: Asymptomatic.
Cyanosis can occur at levels above 5-10%.

20-30%: Moderate symptoms.
- Fatigue, tachypnea, dyspnea, tachycardia.
- Anxiety, dizziness, confusion.
Nausea, vomiting.

> 40%: Severe symptoms can occur:
- Seizure, coma.
- Arrhythmia.
- High lactate.
- Death

CLINICAL FINDINGS:
- central cyanosis
- refractory hypoxaemia (low sats despite high flow oxygen)
- chocolate brown blood

DIAGNOSIS:
ABG - PaO2 will be high >100
ABG or VBG - methaemoglobin level %

MANAGEMENT:
methylene blue 1% 0.1 - 0.2mL/kg (1-2mg/kg IV, over 3 to 5 minutes.

Contraindications:
- G6PD deficiency - may cause haemolysis (need to consult with toxicologist)
- patients prone to serotonin syndrome. Methylene blue is a MAO inhibitor

Additional treatments:
*high dose IV vitamin C and ribolavin (vitamin B12)
*cimetidine for dapsone induce methaemoglobinaemia
*exchange transfusion

G6PD deficiency methaemoglobinaemia:
- need to consult toxicologist
- IV vitamin c and riboflavin vitamin b12
- exchange transfusion
- or trial of methylene blue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Local Anaesthetic Toxicity

A 12 year old boy has had a Biers Block performed for manipulation of a distal radius/ulnar fracture.

During the procedure he develops local anaesthetic toxicity.

A

Nerve blocks:
- High-volume blocks, with doses approaching the maximal safe dose range
- Placement of catheter for prolonged anesthetic infusion.
- Failure to use ultrasound guidance.
- Bupivacaine has greater risks than ropivacaine or lidocaine.

LOCAL ANAESTHETICS MAX DOSING:

  • Bupivacaine 2mg/kg
  • Ropivacaine 2mg/kg
  • Lignocaine 4mg/kg (7mg/kg with adrenaline)
  • Prilocaine 5mg/kg

EARLY SYMPTOMS:
tinnitus, metallic taste, circumoral numbness, blurred vision
- Delirium, dysarthria,

CARDIAC SYMPTOMS 2nd:
- Bradycardia and AV block, widened QRS complexes.
- Hypotension (reduced cardiac contractility)
- Cardiac arrest (VT, VF, PEA, asytole)

ECG - prolonged QRS, terminal R wave in aVR

Respiratory depression and apnoea

Seizures

MANAGEMENT:

Resus
Cardiac monitoring and pulse oximetry
High flow oxygen 15L NRBM
IV access

Treat seizures - midazolam 0.2mg/kg

Treat QRS widening and ventricular dysrythmias:
- Sodium bicarbonate 8.4% 2 mL/kg up to 100 mL
IV every 5 minutes, titrated to a narrowing of the QRS complex <100ms

Lipid emulsion 20% 1.5 mL/kg IV, over 1 minute. Repeat every 5 minutes.

Fluid bolus 20/kg 0.9% SN IV - fluid resuscitation will be guided by POCUS assessment of IVC and LV

Vasopressors with adrenaline infusion starting at 0.05mcg/kg/min titrating up to target a systolic blood pressure of 100-120mmHg

RSI, intubation and hyperventilation to target PCO2 30, pH >7.4

ICU admission
Consider ECMO
Discuss with toxicologist

17
Q

Snake Bite

2021.2 case based discussion

discuss with an examiner the assessment and management of an adult male patient who suspects he has been bitten by a snake.

CLINICAL FEATURES:

COAGULOPATHY:
Venom Induced Consumptive Coagulopathy (VICC)

INR very high or unrecordable
APTT very high or unrecordable
Fibrinogen very low or undetectable
D-dimer very high or unrecordable

fragmented red cells on blood film

Partial VICC
- detectable fibrinogen, INR <3

THROMBOTIC MICROANGIPATHY:
- always associated with VICC
- haemolysis (fragmented red blood cells) on blood film
- thrombocytopenia
- acute renal failure

NEUROTOXICITY:
- descending flaccid paralysis
- 1st eye involvement (ptosis, ophthalmoplegia with diplopia and blurred vision)
- 2nd bulbar palsy (dysarthria, dysphagia)
- 3rd respiratory muscle involvement with respiratory failure
- 4th limb paralysis

MYOTOXICITY:
- Myalgias with rhabdomyolysis
- CK normal on admission, rapidly rises day 2

CARDIOVASCULAR COLLAPSE:
- hypotension and collapse
- cardiac arrest or seizure

ANTICOAGULANT COAGULOPATHY:
- APTT mildly raised, INR and D-dimer normal
- Black snake envenomation
- not clinically important

SYSTEMIC SYMPTOMS:
- nausea and vomiting
- abdominal pain
- diarrhoea
- diaphoresis
- headache

Brown Snakes:
- most common cause of severe envenoming
- geographically everywhere
- minimal pain, redness, swelling with brown snakes
- early collapse, seizure or cardiac arrest in 30%
- VICC in 80%
*brown snake anti-venom available

Tiger Snakes:
- SA and Tasmania
- cause marked pain, redness and swelling at the bite site
- Systemic symptoms common
- Neurotoxicity & myotoxicity 20%
- VICC is rare
*Tiger snake venom available

Black Snakes:
- east coast
- cause pain, redness, swelling at bite site
- anticoagulant coagulopathy (not significant)
- myotoxicity

Taipan:
- northern territory
- cause neurotoxicity

A

EPIDEMIOLOGY:
- majority in rural areas in warmer months
Can manage in a rural setting if:
- laboratory facilities
- antivenom

FIRST AID:

Pressure bandage
- tight, cover the entire limb
Immobilisation

PBI can be removed if no signs of envenomation and normal lab tests.

HISTORY:

Bite pain, redness, swelling, bleeding

Collapse, seizure

Coagulopathy - any bleeding

Neurological toxicity:
- diplopia, blurred vision
- dysphagia, dysarthria, dysphonia
- breathing difficulties
- limb weakness

Myotoxicity - Muscle aches

Systemic toxicity:
- diaphoresis
- headaches
- nausea and vomiting
- diarrhoea
- abdominal pain

EXAMINATION:

Bleeding from snake bite, IV cannulae, haematuria, hemetemesis, intracranial haemorrhage

Neurologica:
- ptosis, ophthalmoplegia, diplopia
- bulbar weakness
- respiratory failure
- limb weakness

Muscle tenderness

INVESTIGATIONS:
Bloods taken on arrival, Repeat 1hr after removal of pressure bandage
Repeat bloods at 6hrs and 12hrs post bite

DO NOT use point of care testing

Coags:
- INR
- APTT

Fibrinogen
D-dimer

FBC:
- Hb drop (haemolysis)
- thrombocytopenia (thrombotic microangiopathy)
- leukocytosis or lymphopenia (non-specific sign of systemic envenoming)

BLOOD FILM is important to look for fragmented RBC’s in thrombotic microangiopathy which would indicate VICC

LDH - haemolysis

Group and Screen - if blood transfusion required

UEC:
- renal failure (thrombotic microangiopathy)
- hyperkalemia

CK:
- myotoxicity and rhabdomyolysis
- may be normal initially

Urine:
- haematuria
- myoglobinuria (rhabdomyolysis)

Choice of antivenom is guided by
- Geography
- Clinical and laboratory findings
- Expert toxicologist consultation

Snake Venom Detection Kits (SVDK)
- swab of bite, can be performed on urine
- can be stored if needed for processing LATER
- can help guide choice of anti-venom (avoid use of polyvalent antivenom) if clinical picture unclear
- complex and operator dependent
- false positives, false negatives and inconclusive results

MANAGEMENT:

ABSOLUTE INDICATIONS FOR ANTI-VENOM:

  • Sudden collapse, cardiac arrest or seizure
  • High INR
  • Paralysis with ptosis and ophthalmoplegia

RELATIVE INDICATIONS:

  • Systemic symptoms (vomiting, headache, diarrhoea etc)
  • Raised aPTT
  • CK >1000
  • Leucocytosis/lymphopenia

One (1) vial of snake antivenom is required to treat both children and adults for all terrestrial
snake envenomings.

Administered in resus with cardiac monitoring due to the risk of anaphylaxis in 5%.
- Premedication with adrenaline or antihistamines is not indicated.
- Diluted in NS given IV over 30min

SERUM SICKNESS:
- warn patients of developing serum sickness
- flu-like symptoms: fever, myalgia, arthralgia, rash develops day 4-14.
- serum sickness can be treated with prednisone 25mg bd (0.5mg/kg)for 5-7 days.
- prophylactive prednisone is not indicated

ANTIVENOM EFFECTS:

VICC - Stops progression

Neurotoxicity - Will reverse if post-synaptic (Death
adder) however will prevent progression
if pre-synaptic (brown or tiger)

Myotoxicity - Stops progression, early administration likely to prevent

Anticoagulant coagulopathy - Rapidly reversed

SAFE DISCHARGE:
- daylight hours - do not discharge overnight
- no physical signs or symptoms of envenomation at 12hrs post bite (VICC, neurotoxicity etc)
- normal bloods at 12hrs post bite

18
Q

Amanita Phalloides

EM Board Bombs ep 219

Key points:
- urgent toxicologist consultation
- mycologist
- decontamination and enhanced elimination with multidose activated charcoal - patient has to be alert and protecting own airway
- haemodialysis for renal failure and metabolic acidosis
- Antidotes (limit the uptake of amatoxin by hepatocytes) - silibinin, benzylpenicillin, rifampicin
- N acetylcystein
- liver transplant

A

CLINICAL FEATURES:
*delayed onset of GI symptoms >6hrs
other non-lethal mushrooms cause GI symptoms soon after eating them

mushroom characteristic - olive brown cap, white stem, white gills, cup like structure at base of stem - *send photos to MYCOLOGIST to confirm mushroom species

amanita phalloides is only in NZ, Victoria, ACT and Adelaide - if ingested mushroom not from these regions, unlikely to be lethal

DISEASE PROGRESSION:

up to 6-12hrs - may be asymptomatic

1-2days:
- severe gastroenetritis (abdominal pain, nausea, vomting, profuse watery diarrhoea)
- dehydration and hypotension
- electrolyte derrangements,
- acute renal failure
- metabolic acidosis
- transaminitis

2-7days:
- gastroenteritis subsides,
- progressive liver failure
- coagulopathy,
- encephalopathy,
- hepatorenal syndrome

> 7 days
- either died 10-30%,
- fully recovered,
- or recovered with chronic hepatitis

INVESTIGATIONS:

VBG - metabolic acidosis
high lactate second to hypoperfusion
UEC - electrolyte disturbances and renal impairment with severe gastroenteritis
LFT - particularly ALT raised in poisoning

MANAGEMENT:
**urgent toxicologist consultation

*management is mainly supportive and aims to limit liver injury and fulminant liver failure

*GI decontamination and enhanced elimination with activated charcoal is critical (reduces mortality)

Patients are alert - no need for airway management

Fluid resuscitation and inotropic support

Correction of electrolyte disturbances

DECONTAMINATION AND ENHANCED ELIMINATION

Place NG tube
Check placement with CXR

(multi-dose activated charcoal)
activated charcoal - 50g Q4hr or place NGT 12.5g/hr continuous feed via enteric pump

Amatoxin undergoes significant enterohepatic recycling, remaining in the portal circulation for a long time after mushroom ingestion. Even if the patient presents 2 days after ingestion, giving activated charcoal is likely to be beneficial.

Dialysis does not remove amanita toxins but may be needed in severe acidosis or renal failure with electrolyte disturbance

PREVENTION OF LIVER INJURY:
- limit uptake of amanita toxic by the liver

*silibinin - 5mg/kg IV over 1hr, then infusion 20mg/kg/24hrs

OR

*benzylpenicillin - 60mg/kg up to 3g IV Q4h

OR rifampicin 600mg IV daily

PLUS

*N-acetylcysteine infusion 200mg/kg IV over 4hrs, then 100mg/kg IV over 16hrs

PLUS

*Thioctic acid 25mg/kg IV Q6h on day 1, 75mg/kg IV Q6h on day 2,

LIVER TRANSPLANTATION

Indications for transfer to liver transplant facility
* INR >6 4 days after ingestion
* Oligouria or Cr >200
* Acidosis pH < 7.3 after resuscitation
*Hypotension SBP < 80
* Hypoglycemia
* Severe thrombocytopenia
* Encephalopathy

Amatoxin can be detected in blood for up to 2 days and in urine for up to 4 days. To reduce the risk of residual amatoxin poisoning in the transplanted liver, wait at least 4 days after ingestion before undertaking a liver transplant.

19
Q

Salicylates (aspirin, oil of wintergreen)

Drugs amenable to haemodialysis

Low volume of distribution
Low protein binding

“PLASMA TV”
Phenobarbital
Lithium
Alcohols (methanol/ethylene glycol)
Salicylates
Metformin-induced lactic acidosis
Theophylline
Valproate

A

Toxic dose >150mg/kg

CLINICAL FEATURES:

**Tachypnoea
Hyperthermia
Gastritis - vomiting, haematemesis
Tinnitus, vertigo, ataxia, deafness.
Delirium, agitation, seizure, coma
Non-cardiogenic pulmonary oedema

INVESTIGATIONS:

VBG - HAGMA, respiratory alkalosis

hypo or hyperglycemia
hypokalemia

Serial salicylate level

MANAGEMENT:

DECNTAMINATION:
prolonged absorption
decontamination with activated charcoal 50g (1g/kg) only if alert with no protracted vomiting

Optimise prior to intubation
Bipap - increase pressure support to increase minute ventilation to blow off CO2
Given 100ml sodium bicarbonate IV (5-10min before intubation so has time to blow off CO2)
most experienced operator
apnoeic BVM ventilation
post intubation hyperventilation to achieve high minute ventilation
TV 8-10ml/kg
RR 25

Avoid acidosis
- Optimise prior to intubation
- BIPAP to blow off CO2, assess minute ventilation for post intubation ventilation settings
- Give 1-2 vials of Sodium Bicarbonate prior to intubation
- Apnoeic BVM ventilation
- Most experienced intubator to get ETT in ASAP
- Hyperventilate once intubated - aim to match pre-intubation minute ventilation as seen on BIPAP

FLUID RESUSCITATION:

fluid resuscitation 20ml/kg 0.9% NS IV

URINE ALKALINIZATION:
sodium bicarbonate 100ml (1 mL/kg ) IV

FOLLOWED BY

sodium bicarbonate 25ml/hr by IV infusion
add 150ml sodium bicarb to 850ml 5% dextrose run at 166ml/hr

MONITOR URINE OUTPUT:
place IDC
aim 1-2ml/kg/hr, urinary pH 7.5

REPLACE K+
30mmol K+ in 1L NS IV over 3hrs targeting K+ 3.5-4.5

TREAT HYPOGLYCAEMIA:
5% dextrose infusion 125ml/hr target bsl 4-11mmol/L

INDICATIONS FOR DIALYSIS:
Renal failure - anuria
Unable to maintain urinary alkalinization
Rising salicylate levels >7.2mmol/L
Severe metabolic acidosis pH <7.1
Renal failure with pulmonary oedema

20
Q

Organophosphate Poisoning

2022.1 Registrar Interaction

advise a junior registrar on the management of a patient presenting after an organophosphate ingestion.

Pesticides and insecticides in agriculture

inhibit anticholinesterase leading to increased acetylcholine activity

dermal absorption and inhalation

Toxicity with 1 mouthful of concentrated solutions

Cholinergic crisis:

“DUMBBELS” - muscurinic effects of cholineesterase inhibition

Diarrhoea
Urination
Miosis
Bradycardia
Bronchorrhoea, bronchospasm
Emesis
Lacrimation
Salivation

Nicotinic effects of cholineesterase inhibition

  • Muscle fasciculations
  • Tremor
  • Weakness
  • Respiratory muscle paralysis
  • Tachycardia
  • Hypertension
  • Mydriasis

CNS

  • agitation
  • confusion
  • coma
  • seizures

Respiratory:
- chemical pneumonitis if aspirated

A

PPE for staff to prevent secondary poisoning

***Large amounts of atropine, hundreds of milligrams, may be necessary in massive ingestions. Proactive contact with the hospital pharmacy (or even other centres) may be necessary to ensure access to adequate amounts of atropine.

DECONTAMINATION:
Removal of clothes and cleaning patient with soap and water.

ANTIDOTE:
Atropine
Initial bolus of 1.2-2.4mg IV (children 20mcg/kg IV).

Double the dose of IV atropine every 5 min to achieve adequate atropinization:

  • Drying of secretions - clear chest
  • Resolution of bradycardia - HR >60

Follow with continuous infusion of 10%–20% per hour of the initial dose of atropine that was required to achieve adequate ­atropinization (typical infusion rates vary from 0.4 to 4 milligrams/h IV in adults).

Adjust infusion rate to maintain adequate atropinization and avoid atropine toxicity (absent bowel sounds, hyperthermia, delirium).

Pralidoxime 30mg/kg IV, followed by infusion 8mg/kg/hr

(Pralidoxime - reverses muscle paralysis by reactivation of acetylholinesterase)

Treat seizures with benzodiazepines

Consult Toxicologist

Admit to ICU

21
Q

Paracetamol Overdose

A

HISTORY:

Time ingestion
Dose ingested - >200mg/kg (or 10g), massive overdose >30mg/kg (0r 30g)
Formulation – immediate vs sustained release
Staggered vs one-off ingestion
Co-ingestants
Self-decontamination ie vomiting
Co-morbidities - pre-existing liver/renal disease
chronic alcoholism, prolonged fasting, on medications that induce cytochrome p450

DECONTAMINATION:
- Within 2 hrs for immediate release ingestion >200mg/kg
- Within 4 hrs for sustained release >200mg/kg
- Massive (>30g) ingestion – within 4 hours immediate release and all SR

Must be alert, no intractable vomiting, maintain own airway

STANDARD NAC REGIMEN:

Bag 1:

200 mg/kg (max 22 g) in 500 mL (glucose 5% or sodium chloride 0.9%) over 4 hours

For paediatrics use a dilution volume of 7mL/kg up to a max of 500 mL

Bag 2:

100 mg/kg (max 11 g) in 1000 mL (glucose 5% or sodium chloride 0.9%) over 16 hours

For paediatrics use a dilution volume of 14 mL/kg up to a max of 1000 mL

DOUBLE DOSE NAC is just 200mg/kg in second bag

INDICATIONS FOR TRANSFER TO TRANSPLANT CENTRE:

  • INR >3 at 48hrs
  • Oligouria or Cr >200
  • Acidosis pH < 7.3 after resuscitation
  • Hypotension SBP < 80
  • Hypoglycemia
  • Severe thrombocytopenia
  • Encephalopathy